Xenetic Biosciences- Warrants (19/07/2024) Profit Margin

As of the most recent data (June 2026), XBIOW shows a profit margin of -75.91%. That compares with -126.03% in the prior-year period — up 39.8% year over year. That is below the Healthcare sector average of 14.34%. Scroll down for historical charts and peer comparison views.

Compared with the year-ago period, XBIOW's profit margin is now -75.91% (was -126.03%) — a 39.8% year-over-year increase. Pairing that YoY change with peer averages gives a clearer picture of whether Xenetic Biosciences- Warrants (19/07/2024) is outperforming or lagging.

The Healthcare sector average profit margin is about 14.34%. Xenetic Biosciences- Warrants (19/07/2024) is at -75.91%, which is lower that average. That is roughly 629.1% below the sector mean. Use the comparison chart on this page to see how XBIOW stacks up against individual peers as well.

That compares with -126.03% in the prior-year period — up 39.8% year over year. Improvement over multiple periods is generally more meaningful than a single strong quarter. Compare Xenetic Biosciences- Warrants (19/07/2024) with peers to see if the move is company-specific or sector-wide.

Besides this profit margin page, Stockcircle has Xenetic Biosciences- Warrants (19/07/2024)'s full stock overview, other financial metrics, insider and congress trade tabs, and tools to follow the stock. Together they help you connect profit margin (currently -75.91%) with ownership activity and broader fundamentals.